Asset-light operations
fully control the high-profit links of the industry chain
Sodium Ibandronate Injection
【Generic Name】:Sodium Ibandronate Injection
【Brand Name】:尚瑞优®
【Medical Insurance Information】:National Medical Insurance Category B
【Pharmaceutical Form】:Concentrate for Solution for Infusion.
【Strengths】:1ml:1mg, 2ml:2mg
【Approval Number】:H20133076, H20133077
【Indication and Usage】:A bisphosphonate indicated for the treatment of bone pain in patients with cancer and bone metastases (when the cancer has spread to the bone), tumour-induced hypercalcaemia with or without metastases and osteoporosis.
【Shelf Life】:24 months
【Manufacturer】:Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
【Distributor】:Sichuan Huaao Pharmaceutical Industry Company